Navigation Links
New Study Reveals Proprietary Saw Palmetto Extract (SPET-085) Supplement Can Effectively Inhibit the Enzyme Linked to Benign Prostatic Hyperplasia (BPH)
Date:7/12/2010

.

While finasteride is currently the most common treatment for BPH, SPEs provide a more natural phytotherapeutic alternative to manage symptoms of the condition. There are many types of SPEs available today, based on a variety of extraction processes.  This study demonstrates that the approach to extraction may impact levels of BPH-related bioactivity among the various extracts of saw palmetto.

"The results of this study verify the high activity of our novel saw palmetto extract, SPET-085, to help maintain healthy prostate function," said Joe Veilleux, General Manager, Euromed USA. "Euromed is committed to ongoing clinical research to provide scientific evidence which will differentiate SPET-085 from other saw palmetto extracts."

About the Study

The nicotinamide adenine dinculeotide phosphate (NADPH)-dependent membrane protein 5alpha-reductase irreversibly catalyses the conversion of testosterone to the most potent androgen, 5alpha-dihydrotestosterone (DHT).  In humans, two 5alpha-reductase isoenzymes are expressed: type I and type II. Type II is found primarily in prostate tissue. Saw palmetto extract (SPE) has been widely used for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH). The mechanisms of the pharmacological effects of SPE include the inhibition 5alpha-reductase, among other actions. Clinical studies of SPE have been equivocal, with some showing significant results and others not. These inconsistent results may be due, in part, to varying bioactivities of the SPE used in the studies.

The aim of the present study was to determine the in vitro potency of a novel saw palmetto ethanol extract (SPET-085) an inhibitor of the 5alpha-reductase isoenzyme type II, in a cell-free test system. On the basis of the enzym
'/>"/>

SOURCE Euromed
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dune Medical Devices Announces Positive Interim Results From EU MarginProbe™ Study Presented at German Breast Cancer Society Meeting
2. Drug Study Shows Improvement in Major Orthopedic Surgery Care
3. Enrollment Underway in CLARITY-AF Study to Compare Efficacy, Safety and Efficiency of Two Catheter Ablation Technologies
4. Nile Therapeutics Completes Dosing of Phase II Study
5. Adeona Completes Equity Financing and Provides Alzheimers Disease Clinical Study Update
6. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant Human Stem Cells
7. China Medical Technologies Announces the Recent Publication of a Study on its SPR Analyzer and HPV DNA Chip in Cancer Genetics and Cytogenetics and the Creation of a Medical Publications Column to the Investor Relations Section on its Website
8. Study Shows Gradual Addition of NovoLog® at Mealtime Can Reduce A1c in Type 2 Diabetes Patients
9. Tolerx Presents Baseline Data from DEFEND-1 Study Validating C-Peptide as Critical Clinical Measure for New-Onset Type 1 Diabetes
10. PARI Pharmas Altera Delivers Gileads Cayston in Head-to-Head Study With Tobramycin Inhalation Solution
11. DURECT Reports Data From European Phase IIb Hysterectomy Study of POSIDUR(TM) (SABER(TM)-Bupivacaine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Research and Markets has announced the ... Surgical) Markets Worldwide 2014" report to their offering. ... The purpose of this report is to analyze and ... Surgical) Gloves. The report discusses key players and identifies ... Topics covered include product definitions, strategies, competitive analysis, market ...
(Date:7/23/2014)... 23, 2014  Nearly 8,000 attendees will converge in ... annual Retail Business Conference (RBC), taking place July 23-26 ... year,s event encourages pharmacists to "Lead Change" in the ... for their future. "RBC is ... with their peers and learn new ways they can ...
(Date:7/23/2014)... 23, 2014  The management team at Columbia ... hold a conference call on July 31, 2014, ... ended June 30, 2014.  The call details are ... 8:30 am EDTDial-in numbers: , Toll free: (877) ... (live & archive): , www.columbialabs.com , under ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2
... --,Alfacell Corporation today announced that in vivo study ... of non-small cell lung cancer (NSCLC) were recently,published ... Based on the work of Intae Lee, Ph.D., ... Efficacy of the Cytotoxic,RNase, Ranpirnase, on A549 Human ...
... Problem of Antibiotic Resistance,Published in Nature Biotechnology, VANCOUVER, ... Inc.'s product candidate IDR-1 is the first,immune system ... to a paper published in the April 2007,issue ... the work of Inimex and its,co-founders Dr. Bob ...
Cached Medicine Technology:In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 2In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 3Inimex Product Candidate is First Immune Defense Regulator to Cure,Infections Without Causing Harmful Inflammation 2
(Date:7/23/2014)... high-profile athletes who suffered repeated blows to the head ... brains. Those clumps suggest the athletes had a disease ... on tests that might be able to detect CTE ... Chemical & Engineering News (C&EN) , the weekly ... the article, Lauren Wolf, a senior editor at C&EN, ...
(Date:7/23/2014)... Spring Hill, FL (PRWEB) July 23, 2014 ... 23 percent reduction in prescription drug deaths from 2010 to ... was infamous for its minimal monitoring of access to some ... into the wrong hands. Florida’s law enforcement launched an ... are now nearly nonexistent compared to the 65 that existed ...
(Date:7/23/2014)... 23, 2014 The Circuelle Foundation ... academic institutions uncovering the importance of breast self-exams ... need for breast self-exams is contradictory and can ... today for keeping this healthy ritual. , “Women ... the significance of breast self-exams and becoming breast ...
(Date:7/23/2014)... Hills, CA (PRWEB) July 23, 2014 ... now offers facial plastic surgery procedures to patients who ... address signs of aging affecting any part of the ... in the way they want. Throughout life, facial skin ... make patients look older than they really are. Each ...
(Date:7/23/2014)... recording was low and calm as the speaker recounted the telephone ... immunodeficiency virus (HIV) that causes AIDS: "My heart just stopped for ... the floor flat on my face boohooing, crying like a baby." ... than 10 minutes later. "Don,t feel like this is the end ... setting you up for something greater," the anonymous speaker tells an ...
Breaking Medicine News(10 mins):Health News:Florida’s Crackdown on Pill Mills Has Led to Rise in Popularity of Synthetic Drugs; Suncoast Rehab Educates on Dangers of These Drugs in Adolescents 2Health News:Florida’s Crackdown on Pill Mills Has Led to Rise in Popularity of Synthetic Drugs; Suncoast Rehab Educates on Dangers of These Drugs in Adolescents 3Health News:Florida’s Crackdown on Pill Mills Has Led to Rise in Popularity of Synthetic Drugs; Suncoast Rehab Educates on Dangers of These Drugs in Adolescents 4Health News:Historical and Current Research Points to Importance of Breast Self-Exams 2Health News:Beverly Hills Plastic Surgeon, Dr. Diamond, is Now Offering Facial Plastic Surgery Procedures 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 2
... Aug. 10 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited (NYSE: MR ... today its selected unaudited,financial results for the second quarter and first ... for Second Quarter and First Half 2009, -- ... 9.9% over the second quarter ...
... , , FRAMINGHAM, Mass. ... HTWR ) (ASX: HIN) today announced that it has entered into ... United States to sell approximately 2.5 million shares of its common ... have agreed to purchase the shares at a purchase price of ...
... familial history of disease were protected , MONDAY, Aug. 10 ... short periods of time may lower their risk of developing ... the disease. , "We saw a 59 percent lower ... who had ever breast-fed," stated Dr. Alison Stuebe, lead author ...
... , WASHINGTON, Aug. 10 One out ... immigrant (legal or illegal) or the U.S.-born child (under 18) of ... those on Medicaid. While there has been some discussion of ... the enormous impact of immigration, both legal and illegal, on the ...
... Life(R) Announces Search for Family of the Year -- Winning Family Receives Trip ... Expert , , GREENWICH, Conn., Aug. 10 Think ... As part of its Pure Life / B e ... healthy habits, Ne s tle(R) Pure Life(R) bottled water ...
... , , PALO ALTO, Calif., ... announced that it will report its second quarter 2009 financial results on ... and live webcast to discuss the results, provide guidance for 2009, and ... Time/2:00 p.m. Pacific Time. , , The live webcast ...
Cached Medicine News:Health News:Mindray Announces Second Quarter 2009 Financial Results 2Health News:Mindray Announces Second Quarter 2009 Financial Results 3Health News:Mindray Announces Second Quarter 2009 Financial Results 4Health News:Mindray Announces Second Quarter 2009 Financial Results 5Health News:Mindray Announces Second Quarter 2009 Financial Results 6Health News:Mindray Announces Second Quarter 2009 Financial Results 7Health News:Mindray Announces Second Quarter 2009 Financial Results 8Health News:Mindray Announces Second Quarter 2009 Financial Results 9Health News:Mindray Announces Second Quarter 2009 Financial Results 10Health News:Mindray Announces Second Quarter 2009 Financial Results 11Health News:Mindray Announces Second Quarter 2009 Financial Results 12Health News:Mindray Announces Second Quarter 2009 Financial Results 13Health News:Mindray Announces Second Quarter 2009 Financial Results 14Health News:Mindray Announces Second Quarter 2009 Financial Results 15Health News:Mindray Announces Second Quarter 2009 Financial Results 16Health News:Mindray Announces Second Quarter 2009 Financial Results 17Health News:Mindray Announces Second Quarter 2009 Financial Results 18Health News:HeartWare International, Inc. Announces US$55 Million Financing 2Health News:HeartWare International, Inc. Announces US$55 Million Financing 3Health News:Breast-Feeding May Lower Breast Cancer Risk 2Health News:Breast-Feeding May Lower Breast Cancer Risk 3Health News:Could Your Family Be The 'Family of the Year?' 2Health News:Could Your Family Be The 'Family of the Year?' 3Health News:Could Your Family Be The 'Family of the Year?' 4Health News:Could Your Family Be The 'Family of the Year?' 5